← All indications
Pulmonary Alveolar Proteinosis
A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.
Drugs by status
Phase 3 trials (1)
Phase 2 trials (4)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (12)
Organization Involved with Phase 1 Indications (5)